via Imperial College London
A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing.
The chip, developed at Imperial College London and known as TriSilix, is a ‘micro laboratory’ which performs a miniature version of the polymerase chain reaction (PCR) on the spot. PCR is the gold-standard test for detecting viruses and bacteria in biological samples such as bodily fluids, faeces, or environmental samples.
Rather than sending swabs to the lab or going to a clinic, the lab could come to you on a fingernail-sized chip.
Dr Firat Güder – Department of Bioengineering
Although PCR is usually performed in a laboratory, which means test results aren’t immediately available, this new lab-on-a-chip can process and present results in a matter of minutes.
The chip is made from silicon, the same material that is used to make electronic chips. Silicon itself is cheap, however it is expensive to process into chips as this requires massive, extremely clean factories known as cleanrooms.
To make the new lab-on-chip, the researchers developed a series of methods to produce the chips in a standard laboratory, cutting the costs and time they take to fabricate, potentially allowing them to be produced anywhere in the world.
Lead researcher Dr Firat Güder of Imperial’s Department of Bioengineering said: “Rather than sending swabs to the lab or going to a clinic, the lab could come to you on a fingernail-sized chip. You would use the test much like how people with diabetes use blood sugar tests, by providing a sample and waiting for results – except this time it’s for infectious diseases.”
The paper is published in Nature Communications.
The researchers have so far used TriSilix to diagnose a bacterial infection mainly present in animals as well as a synthetic version of the genetic material from SARS-CoV-2, the virus behind COVID-19.
The researchers say the system could in future be mounted onto handheld blood sugar test-style devices. This would let people test themselves and receive results at home for colds, flu, recurrent infections like those of the urinary tract (UTIs), and COVID-19.
Table-top devices for testing of infections like COVID-19 already exist, but these tests can be time-consuming and costly since the patient must go to a clinic, have a sample taken by a healthcare worker and go home or stay in clinic to wait. People leaving their homes when not feeling well increases the risk of spread of a pathogen to others.
If validated on human samples, this new test could provide results outside a clinic, at home or on-the-go within minutes.
(This) could help patients, with the help of their doctor, to personalise and tailor their antibiotic use to help reduce the growing problem of antibiotic resistance. Dr Estefania Nunez-Bajo – Department of Bioengineering
The researchers also say a highly portable test could accelerate diagnosis of infections and reduce costs by eliminating transportation of samples. Such tests could be performed by citizens in the absence of highly trained medical professionals – hence, if they need to self-isolate, they can start immediately without potentially infecting others.
Making testing more accessible and cheaper is especially important for people in rural areas of low-income countries, where clinics can be far away and expensive to travel to. If made available to patients, it could also be used to diagnose and monitor infections like UTIs, which often recur despite antibiotics.
First author Dr Estefania Nunez-Bajo, also of the Department of Bioengineering, said: “Monitoring infections at home could even help patients, with the help of their doctor, to personalise and tailor their antibiotic use to help reduce the growing problem of antibiotic resistance.”
Each lab-on-a-chip contains a DNA sensor, temperature detector and heater to automate the testing process. A typical smartphone battery could power up to 35 tests on a single charge.
Next, the researchers plan to validate their chip with clinical samples, automate the preparation of samples and advance their handheld electronics. They are looking for partners and funders to help accelerate the translation of the technology and deliver testing at resource limited settings at homes, farms or remote locations in the developing world.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Handheld infectious disease testing
- How fast could SARS-CoV-2 be detected?on January 25, 2021 at 2:17 pm
In the past 20 years, humans have suffered several serious epidemics from emerging viruses, such as SARS, swine flu, Ebola, MERS and (most recently) SARS-CoV-2. During each epidemic, an accurate, ...
- New Clinical Data Shows BD Antigen Test May Be More Selective In Detecting Infectious COVID-19 Patients Than Molecular Testson January 25, 2021 at 4:14 am
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the publication of a peer-reviewed study that shows BD's antigen test may be more selective than PCR ...
- 'Hard truths and important facts': Biden pushes for coronavirus testing reset with $50 billion planon January 24, 2021 at 1:29 pm
Biden's $50 billion coronavirus testing fix calls for a new federal testing board, more supplies, rapid tests and better technology to fill gaps ...
- Spartan Bioscience says Health Canada approves rapid COVID-19 teston January 24, 2021 at 8:02 am
Ottawa-based Spartan Bioscience has received Health Canada approval for its made-in-Canada rapid COVID-19 test, authorizing the sale of the device. "The Spartan COVID-19 System offers the speed and ...
- A pandemic playbook for a new yearon January 23, 2021 at 6:12 pm
It has been about a year since the first reported case of Covid-19 in the United States, a day that changed our country forever. We asked eight experts how they would advise the Biden administration ...
Go deeper with Google Headlines on:
Handheld infectious disease testing
Go deeper with Bing News on:
Infectious disease testing
- Moderna says its COVID-19 vaccine protects against new UK and South African variants but plans to test new booster shoton January 25, 2021 at 3:56 pm
Moderna says studies show its vaccine is effective against emerging strains of the coronavirus but plans to test a booster to its two-dose regimen.
- Two weeks into a test run, Mass. jury trials go on pauseon January 25, 2021 at 3:16 pm
After conducting five jury trials over the last two weeks, Massachusetts trial courts have opted to put the proceedings on hold from Tuesday until Feb. 12, court officials said. D ...
- Overnight Health Care: Biden says anyone who wants vaccine may be able to get it by spring | Moderna says vaccine effective on variants, but tests booster shot | California ...on January 25, 2021 at 3:15 pm
Welcome to Monday's Overnight Health Care. President Biden has a new timeline for vaccinating everyone who wants to be, and his administration is also going to resume coronavirus briefings with health ...
- Moderna will test booster dose for COVID vaccine after weaker immune response found to new varianton January 25, 2021 at 11:51 am
The pharmaceutical company is taking the precaution of testing a possible booster dose against the strain discovered in South Africa.
- Free At-Home COVID-19 Tests Are An 'Additional Tool' For Wisconsin's Fight Against COVID-19on January 25, 2021 at 11:32 am
Wisconsin residents ages four and up can now get at-home COVID-19 test kits for free through a partnership between the state of Wisconsin and Vault Medical ...